NASDAQ Top Percentage Gainers; (OUTD), (CLVS), (IIJI), (AMRI)
Ideas get bigger when you share them...
Visit: Outdoor Channel Holdings Inc.
New York, New York - March 4, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for March 4th, 2013.
Outdoor Channel Holdings Inc., (NASDAQ:OUTD) trading at $8.67 gained $1.12 or 14.87% on a volume of 531,289 shares, making it today's top percentage gainer on the NASDAQ.
Outdoor Channel Holdings Inc., the owner of a cable-TV network with hunting and fishing programs, said it received an unsolicited $227 million takeover bid from Kroenke Sports & Entertainment LLC.
The $8.75-a-share cash offer appears to be superior to the TV-network company's previously announced plan to merge with InterMedia Outdoor Holdings Inc., Outdoor Channel announced earlier today in a statement. The board has authorized talks with Kroenke.
The new offer may thwart closely held InterMedia's plan to produce a new publicly traded company combining its Sportsman Channel and 15 magazines with Outdoor Channel. InterMedia had offered Outdoor Channel investors a choice of $8 cash a share, a new share of the new company or a combination of $4.46 in cash and 0.443 shares.
InterMedia said earlier today in a statement that Kroenke's bid isn't a superior offer, based on the value of comparable companies and the savings InterMedia would get by combining with Outdoor Channel.
Clovis Oncology Inc., (NASDAQ:CLVS) trading at $24.64 rose by $2.83 or 12.98% on a volume of 89,549 shares.
Internet Initiative Japan Inc., (NASDAQ:IIJI) trading at $14.48 moved up $1.03 or 7.66% on a light volume of 8,750 shares.
Albany Molecular Research Inc., (NASDAQ:AMRI) trading at $8.68 gained $0.68 or 8.50% on a volume of 597,766 shares.
AMRI announced earlier today that it has promoted Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia. Dr. Yura will report directly to Thomas E. D'Ambra, Ph.D., Chairman, President and CEO.
Dr. Yura joined AMRI in January 2011 and most recently served as Senior Director of Drug Discovery services in Singapore, leading the chemistry and biology teams of AMRI's flagship Asian integrated drug discovery operations. Effective immediately, Dr. Yura has also assumed leadership of AMRI's Discovery and Development efforts at AMRI's Hyderabad, India site.
Dr. Yura brings to this role more than 22 years of scientific and leadership experience in discovery research, project management and business development. Before joining AMRI, he was a director at Dishman Japan Ltd., responsible for sales and all business development activities for contract manufacturing services. Before that, he served as discovery chemistry research head at Pfizer Japan, dedicated primarily to the areas of pain and gastrointestinal drug discovery. Prior to Pfizer, he served as section head, medicinal chemistry at Bayer Yakuhin in Japan focused on urology and asthma. He has held additional scientific roles at both Ciba Geigy Japan and Tanabe Seiyaku. Dr. Yura obtained a Ph.D. in synthetic organic chemistry at the University of Tokyo, working with Professor Teruaki Mukaiyama until his retirement and with Professor Koichi Narasaka. He also holds an M.B.A. from the Temple University Tokyo.
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com